In a bold move, President Trump is set to sign an executive order mandating the U.S. health department to negotiate lower drug prices with pharmaceutical companies. This could drastically change healthcare costs for millions of Americans.
In a surprising announcement, Trump declares he will sign an executive order to slash prescription drug prices in the U.S. to match those of other high-income countries, potentially reducing costs by 30% to 80%.
In a surprising move, President Trump has nominated Casey Means, a health entrepreneur and advocate for a controversial health agenda, as the new Surgeon General, replacing Janette Nesheiwat amid credential controversies.
As President Trump prepares to unveil a major tariff plan, pharmaceutical companies are lobbying for a gradual implementation to mitigate the impact on drug prices and supply. With potential tariffs looming, how will the industry adapt?
